Search Results

There are 1848 results for: content related to: Treatment of youth with bipolar disorder: long-term versus maintenance

  1. You have free access to this content
    Aripiprazole versus other atypical antipsychotics for schizophrenia

    Intervention Review

    The Cochrane Library

    Priya Khanna, Tao Suo, Katja Komossa, Huaixing Ma, Christine Rummel-Kluge, Hany George El-Sayeh, Stefan Leucht and Jun Xia

    Published Online : 2 JAN 2014, DOI: 10.1002/14651858.CD006569.pub5

  2. You have free access to this content
    Aripiprazole alone or in combination for acute mania

    Intervention Review

    The Cochrane Library

    Rachel Brown, Matthew J Taylor and John Geddes

    Published Online : 17 DEC 2013, DOI: 10.1002/14651858.CD005000.pub2

  3. Aripiprazole for schizophrenia

    Intervention Review

    The Cochrane Library

    Hany George El-Sayeh and Carla Morganti

    Published Online : 19 APR 2006, DOI: 10.1002/14651858.CD004578.pub3

  4. Aripiprazole for autism spectrum disorders (ASD)

    Intervention Review

    The Cochrane Library

    Lauren E Hirsch and Tamara Pringsheim

    Published Online : 26 JUN 2016, DOI: 10.1002/14651858.CD009043.pub3

  5. Aripiprazole versus typical antipsychotic drugs for schizophrenia

    Intervention Review

    The Cochrane Library

    Jayanti Bhattacharjee and Hany G El-Sayeh

    Published Online : 16 JUL 2008, DOI: 10.1002/14651858.CD006617.pub3

  6. Aripiprazole in schizophrenia: consensus guidelines

    International Journal of Clinical Practice

    Volume 59, Issue 4, April 2005, Pages: 485–495, M. J. Travis, 1 T. Burns, 2 S. Dursun, 3 T. Fahy, 1 S. Frangou, 1 R. Gray, 1 P. M. Haddad, 4 R. Hunter, 5 D. M. Taylor and 6 A. H. Young 7

    Version of Record online : 21 MAR 2005, DOI: 10.1111/j.1368-5031.2005.00498.x

  7. Aripiprazole versus placebo for schizophrenia

    Intervention Review

    The Cochrane Library

    Ravindra B Belgamwar and Hany George G El-Sayeh

    Published Online : 10 AUG 2011, DOI: 10.1002/14651858.CD006622.pub2

  8. Aripiprazole plus divalproex for recently manic or mixed patients with bipolar I disorder: a 6-month, randomized, placebo-controlled, double-blind maintenance trial

    Human Psychopharmacology: Clinical and Experimental

    Volume 26, Issue 8, December 2011, Pages: 543–553, Young Sup Woo, Won-Myong Bahk, Moon Yong Chung, Do-Hoon Kim, Bo-Hyun Yoon, Jong Hun Lee, Yong Min Ahn, Sang-Keun Chung, Jeong-Gee Kim, Kwang Heun Lee and Ki-Chung Paik

    Version of Record online : 2 DEC 2011, DOI: 10.1002/hup.1240

  9. Aripiprazole for the treatment of pediatric bipolar I disorder: a 30-week, randomized, placebo-controlled study

    Bipolar Disorders

    Volume 15, Issue 2, March 2013, Pages: 138–149, Robert L Findling, Christoph U Correll, Margaretta Nyilas, Robert A Forbes, Robert D McQuade, Na Jin, Svetlana Ivanova, Raymond Mankoski, William H Carson and Gabrielle A Carlson

    Version of Record online : 25 FEB 2013, DOI: 10.1111/bdi.12042

  10. A sensitive column-switching HPLC method for aripiprazole and dehydroaripiprazole and its application to human pharmacokinetic studies

    Journal of Separation Science

    Volume 33, Issue 21, November 2010, Pages: 3292–3298, Yumiko Akamine, Norio Yasui-Furukori, Midori Kojima, Yoshimasa Inoue and Tsukasa Uno

    Version of Record online : 3 NOV 2010, DOI: 10.1002/jssc.201000457

  11. Efficacy and safety of adjunctive aripiprazole in major depressive disorder in older patients: a pooled subpopulation analysis

    International Journal of Geriatric Psychiatry

    Volume 26, Issue 6, June 2011, Pages: 564–572, David C. Steffens, J. Craig Nelson, James M. Eudicone, Candace Andersson, Huyuan Yang, Quynh-Van Tran, Robert A. Forbes, Berit X. Carlson and Robert M. Berman

    Version of Record online : 9 SEP 2010, DOI: 10.1002/gps.2564

  12. Aripiprazole in combination with lamotrigine for the long-term treatment of patients with bipolar I disorder (manic or mixed): a randomized, multicenter, double-blind study (CN138-392)

    Bipolar Disorders

    Volume 14, Issue 1, February 2012, Pages: 41–53, Berit X Carlson, Terence A Ketter, Wei Sun, Karen Timko, Robert D McQuade, Raymond Sanchez, Estelle Vester-Blokland and Ronald Marcus

    Version of Record online : 13 FEB 2012, DOI: 10.1111/j.1399-5618.2011.00974.x

  13. Attenuation of reinforcing and psychomotor stimulant effects of amphetamine by aripiprazole

    Addiction Biology

    Volume 16, Issue 1, January 2011, Pages: 55–63, Pia Bäckström, Tiina J. Etelälahti and Petri Hyytiä

    Version of Record online : 23 JUN 2010, DOI: 10.1111/j.1369-1600.2010.00223.x

  14. Lack of a pharmacokinetic drug–drug interaction between lithium and valproate when co-administered with aripiprazole

    Journal of Clinical Pharmacy and Therapeutics

    D. W. Boulton, G. D. Kollia, S. Mallikaarjun and D. M. Kornhauser

    Version of Record online : 14 MAY 2012, DOI: 10.1111/j.1365-2710.2012.1331.x

  15. Simultaneous determination of aripiprazole and its active metabolite, dehydroaripiprazole, in plasma by capillary electrophoresis combining on-column field-amplified sample injection and application in schizophrenia

    ELECTROPHORESIS

    Volume 31, Issue 16, August 2010, Pages: 2778–2786, Pei-Lin Hwang, Shao-Yun Wei, Hsin-Hua Yeh, Ju-Yun Ko, Cheng-Chen Chang and Su-Hwei Chen

    Version of Record online : 21 JUL 2010, DOI: 10.1002/elps.201000237

  16. Lack of a pharmacokinetic drug–drug interaction between lithium and valproate when co-administered with aripiprazole

    Journal of Clinical Pharmacy and Therapeutics

    Volume 37, Issue 5, October 2012, Pages: 565–570, D. W. Boulton, G. D. Kollia, S. Mallikaarjun and D. M. Kornhauser

    Version of Record online : 3 SEP 2012, DOI: 10.1111/j.1365-2710.2012.01331.x

  17. Use of aripiprazole for delirium in the elderly: a short review

    Psychogeriatrics

    Volume 15, Issue 1, March 2015, Pages: 75–84, Eiji Kirino

    Version of Record online : 17 DEC 2014, DOI: 10.1111/psyg.12088

  18. Pharmacokinetics of Aripiprazole and Concomitant Lithium and Valproate

    The Journal of Clinical Pharmacology

    Volume 45, Issue 1, January 2005, Pages: 89–93, Dr Leslie Citrome, Dr Richard Josiassen, Dr Nigel Bark, Dr Daniel E. Salazar and Dr Suresh Mallikaarjun

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270004269870

  19. Response and remission rates with adjunctive aripiprazole in patients with major depressive disorder who exhibit minimal or no improvement on antidepressant monotherapy

    International Journal of Clinical Practice

    Volume 68, Issue 11, November 2014, Pages: 1301–1308, D. E. Casey, K. K. Laubmeier, J. M. Eudicone, R. Marcus, R. M. Berman, Z. Rahman and J. Sheehan

    Version of Record online : 6 SEP 2014, DOI: 10.1111/ijcp.12480

  20. Effects of aripiprazole and its active metabolite dehydroaripiprazole on the activities of drug efflux transporters expressed both in the intestine and at the blood–brain barrier

    Biopharmaceutics & Drug Disposition

    Volume 33, Issue 6, September 2012, Pages: 304–315, Yasuhisa Nagasaka, Kazuo Oda, Takafumi Iwatsubo, Akio Kawamura and Takashi Usui

    Version of Record online : 18 AUG 2012, DOI: 10.1002/bdd.1801